What is a Silent Panic Attack

Does TMS therapy work? For many people whose depression has not responded to antidepressants, yes, and the research shows how many. The FDA cleared transcranial magnetic stimulation (TMS) for major depressive disorder in 2008 on the strength of sham-controlled trials, and more than a decade of real-world outcome data has followed. What the evidence does not support is an unqualified "TMS works." Outcomes vary from person to person, the numbers depend on how you define success, and the people who benefit most share a recognizable profile.

‍

Start with the definitions, because every statistic below depends on them.

What "Works" Means: Response vs. Remission

Depression research measures success on rating scales, and two thresholds matter.

‍

Response means a meaningful reduction in symptoms, usually defined as a 50% or greater drop in the score on a standard depression scale. Someone who responds feels noticeably better but may still have symptoms.

‍

Remission means the score falls below the scale's cutoff for depression. Symptoms are largely gone. Remission is the goal of treatment, and it is the harder bar to clear.

‍

Two more details shape every TMS success rate you will read. The scale matters: clinician-rated scales and patient questionnaires produce different numbers for the same group of people. And the population matters. TMS is studied almost entirely in people whose depression has already failed to respond to medication, so its rates should be compared with other treatments for that same group, not with a first antidepressant.

What the Clinical Evidence Shows

One of the key trials confirming TMS's effect was a randomized, sham-controlled study led by Mark George and published in Archives of General Psychiatry in 2010. It enrolled 199 adults with major depression who were not taking antidepressants, with 190 included in the analysis. During the blinded phase, 14.1% of people receiving active TMS reached remission, compared with 5.1% receiving sham stimulation. The odds of remission were 4.2 times higher with real treatment, and the number needed to treat was 12.

‍

Those figures look modest next to many TMS marketing pages. The blinded phase was short, the remission bar strict, and a sham-controlled design exists to prove an effect is real, not to show the best a treatment can do in practice. On that goal, it succeeded.

‍

Real-world outcomes come from a different kind of study. In 2012, Linda Carpenter and colleagues published a multisite observational study in Depression and Anxiety covering 307 outpatients treated at 42 clinical TMS practices across the United States. These patients had already tried an average of 2.5 antidepressants at adequate dose and duration without satisfactory improvement. By the end of treatment, 58% had responded and 37.1% were in remission on the clinician-rated scale. On the PHQ-9, a self-report questionnaire, 56.4% responded and 28.7% reached remission.

‍

Our own framing for patients is deliberately conservative: roughly half of people respond and roughly one in three reach remission, and those figures describe people who had not benefited from four or more antidepressants. So how effective is TMS for depression? For depression that has resisted medication, it helps about half of the people who complete a standard course, and it clears depression for about a third.

‍

One clarification about higher numbers you may have seen. Remission rates of 70% or 80% come from newer accelerated protocols, many sessions per day over about a week guided by brain imaging, in small early trials. The FDA has cleared a rapid-acting form of TMS, as the National Institute of Mental Health notes, but we do not offer accelerated protocols, and the figures in this article describe the standard daily course our clinics provide.

TMS Compared to Other Depression Treatments

Antidepressant medication remains first-line, and TMS is typically considered after it. Compared with switching to yet another medication, TMS acts on the brain directly rather than through the bloodstream, which is why it does not cause weight gain, sexual side effects, or sedation.

‍

Electroconvulsive therapy (ECT) produces larger and faster symptom reduction in head-to-head research, but it requires general anesthesia and can affect memory around the time of treatment, so it is reserved for severe or urgent situations. Esketamine (Spravato) and ketamine can act within days rather than weeks, with a different monitoring burden and a different side-effect profile. None of these is universally better. They suit different clinical pictures, and we compare each pairing in depth in dedicated articles.

Who Is Most Likely to Benefit

The evidence points to a consistent profile of the person who does well with TMS. It matches the eligibility criteria we use, which also track what insurers require for authorization:

‍

• A confirmed diagnosis of major depressive disorder. TMS is cleared for MDD, not for every kind of low mood, and getting the diagnosis right comes first. If you are unsure how your diagnosis fits, our guide to major depressive disorder vs. persistent depressive disorder explains the distinction.
• Multiple antidepressants from different classes that did not bring adequate improvement.
• Psychotherapy that was tried and did not bring enough relief.
• No medical contraindications. TMS uses a strong magnetic field, so we screen for a history of seizures or epilepsy, metal in the head outside the mouth, implanted devices such as pacemakers, and a history of stroke, neurosurgery, or brain injury. Pregnancy calls for individualized planning with your obstetric and psychiatric team. Ordinary dental fillings are not a problem.
• The ability to commit to a daily session schedule for several weeks.

‍

Notice what is not on the list: how many years you have spent on medication. More than half of the Carpenter study's patients responded after multiple failed medication trials.

How Long It Takes to See Results

TMS is cumulative. A single session produces nothing you would notice; the benefit builds as repeated stimulation changes activity in the mood circuits being targeted. At our clinics, a full course of TMS means 20 to 30 weekday sessions over roughly four to six weeks.

‍

When improvement shows up varies. Some people notice sleep, energy, or concentration shifting in the second or third week, often before their mood lifts. Others feel little change until the final stretch of the course. Both patterns are normal, and neither predicts the final outcome well, which is why progress is judged with symptom rating scales rather than a mid-course impression. The most common mistake is writing TMS off after a handful of sessions.

What Happens If TMS Doesn't Work?

It is a fair question to ask before you start, and the answer is not "you are out of options."

‍

If symptom scores have not moved by the later part of the course, a psychiatrist reassesses rather than simply stopping. The treatment plan can be adjusted, including the stimulation parameters or the length of the course. Medication can be changed or added, since TMS and medication are often combined. Psychotherapy can be intensified. And other options for treatment-resistant depression remain on the table, including esketamine and, for severe or urgent depression, ECT.

‍

Partial response is its own category: a 30% drop in symptoms is not a treatment failure, and it often shapes what comes next. People who responded well to a first course can also be treated again if depression returns.

‍

What happens if TMS doesn't work is, in the end, what happens at every stage of treating difficult depression: the plan changes, and the person stays in care. If you are having thoughts of suicide at any point, call or text 988 to reach the Suicide and Crisis Lifeline.

What TMS Does Not Do

TMS is a specific tool, and its limits are as well defined as its strengths.

‍

It does not work for everyone. About half of people with medication-resistant depression respond, which means about half do not.

‍

It is not a first-line treatment. In practice, and in insurers' criteria, TMS comes after antidepressant trials, not instead of them.

‍

It is not a general-purpose brain treatment. The FDA clearances are specific: major depressive disorder since 2008 and obsessive-compulsive disorder since 2018, plus a small number of narrowly defined uses. Anxiety disorders and PTSD are being studied, but those uses are not cleared. At our clinics we currently provide TMS for major depressive disorder.

‍

It is not a cure. Remission is a realistic goal, but depression can return, and TMS belongs inside ongoing care rather than serving as a one-time fix.

What to Expect During a Course of Treatment

The practical side is simpler than most people expect.

‍

Treatment begins with a screening visit of 30 to 60 minutes to confirm the diagnosis, review your treatment history, and check for contraindications. Sessions then run Monday through Friday, 30 to 40 minutes each. You sit in a chair, awake, while a magnetic coil rests against your scalp and delivers pulses in short trains. It feels like tapping. With no anesthesia or sedation, you drive yourself home and go straight back to your day.

‍

Side effects are mostly local and mostly early: scalp discomfort at the coil site and headache, both of which typically clear within the first week. Because nothing enters your bloodstream, TMS does not cause the weight gain, sexual dysfunction, stomach upset, dry mouth, or sedation that antidepressants can. The one serious risk, seizure, is exceedingly rare, and the screening process exists to keep it that way.

Talking to a Psychiatrist About Whether TMS Is Right for You

Population statistics tell you what TMS does for people like you. They cannot tell you what it will do for you. That question gets answered in an evaluation, where a psychiatrist reviews your diagnosis, medication history, health, and goals, and tells you plainly whether TMS is a reasonable next step.

‍

At Amae, TMS is one part of an integrated care model in which psychiatry, therapy, primary care, and peer support come from the same team, so a course of TMS fits into your broader care rather than running alongside it. We provide it in Los Angeles, Los Altos, and San Mateo, all commercial insurance plans are accepted alongside cash pay, and prior authorization is handled by our intake team. To find out where you stand, schedule an evaluation with an Amae psychiatrist.

Frequently Asked Questions

What percentage of people does TMS work for?

In a major multisite real-world study, 58% of patients responded and 37% reached remission on clinician ratings after a standard course. Those patients had already tried an average of 2.5 antidepressants without adequate relief, so the numbers describe treatment-resistant depression, not depression in general. Our own conservative framing is that about half respond and about one in three reach remission.

How soon does TMS start working?

Gradually, over the course rather than after a single session. Some people notice changes in sleep, energy, or focus within the first two or three weeks, while others see improvement only near the end of the four-to-six-week course. Neither pattern reliably predicts the final result.

Does TMS work for everyone?

No. Like every treatment for depression, TMS produces a range of outcomes, and roughly half of people with medication-resistant depression do not respond. That is why a psychiatrist tracks symptoms during the course and adjusts the plan if progress stalls.

Is TMS FDA-approved or still experimental?

TMS is FDA-cleared, not experimental. Clearance for major depressive disorder came in 2008 and for obsessive-compulsive disorder in 2018, both on the basis of controlled clinical trials. Uses such as anxiety disorders and PTSD are still at the research stage and are not cleared.

What happens if TMS doesn't work for me?

A psychiatrist reassesses and lays out next steps. Those can include adjusting the treatment plan, combining TMS with medication changes or psychotherapy, or considering other treatment-resistant depression options such as esketamine or ECT. Not responding to TMS does not mean nothing else will work.

How long do the effects of TMS last?

It varies. Improvement often lasts well beyond the end of the course, some people need a maintenance plan or a repeat course, and the timing differs from person to person. Durability deserves its own discussion, and it is one to have with your psychiatrist as you approach the end of a course.

‍

Citations

1. George MS, Lisanby SH, Avery D, et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry. 2010. https://pubmed.ncbi.nlm.nih.gov/20439832/
2. Carpenter LL, Janicak PG, Aaronson ST, et al. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety. 2012. https://pubmed.ncbi.nlm.nih.gov/22689344/
3. Micallef-Trigona B. Comparing the effects of repetitive transcranial magnetic stimulation and electroconvulsive therapy in the treatment of depression: a systematic review and meta-analysis. Depression Research and Treatment. 2014. https://pubmed.ncbi.nlm.nih.gov/25143831/
4. National Institute of Mental Health. Brain Stimulation Therapies. https://www.nimh.nih.gov/health/topics/brain-stimulation-therapies/brain-stimulation-therapies
5. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍

From the outside, you look fine. You show up, you apologize first, you keep your voice level. Inside, a small comment from a friend can set off hours of shame, a spiral of "they're going to leave," and a quiet decision to pull away before anyone can hurt you. That pattern has a name people search for: quiet BPD. It describes borderline personality disorder (BPD) turned inward, where the intense emotions are real but almost nobody sees them.

Quiet BPD isn't a separate diagnosis. It's a way of describing how BPD can look when anger, fear, and despair are directed at yourself instead of at other people. And because it's so easy to miss, people often live with it for years before anyone names it.

Is quiet BPD a real diagnosis?

Not formally. The DSM-5 describes one borderline personality disorder, with no official subtypes. "Quiet BPD," "silent BPD," "internalized BPD," and "hidden BPD" are informal terms that patients and clinicians use for the same inward-facing pattern.

The idea has roots in research, though. Psychologist Theodore Millon described four subtypes of BPD, including a "discouraged" type and a "petulant" type. The discouraged type, marked by avoidant and dependent traits, unexpressed anger, guilt, and shame, is the closest match to what people now call quiet BPD. (We've written separately about the outward-facing petulant type of BPD.)

Newer data points the same way. A 2023 study of 109 patients with BPD in a psychiatric day clinic, published in Personality Disorders: Theory, Research, and Treatment, sorted patients into three groups by symptom pattern. Thirty-five fit an "internalizing" profile, and that group had more co-occurring mood disorders than the others.

So the label is informal. The pattern is not.

Quiet BPD symptoms and signs

The core symptoms of quiet BPD are the same ones the NIMH lists for borderline personality disorder. What changes is the direction they travel.

• Fear of abandonment shows up as hypervigilance and pre-emptive withdrawal. You don't beg someone to stay. You leave first, or go silent, so the rejection can't land.
• Intense, shifting moods happen behind a calm face. An episode can last a few hours to a few days, and the people around you may never know it happened.
• Anger gets swallowed and turned into self-criticism. Instead of an outburst, there's a long internal prosecution of everything you did wrong.
• An unstable sense of self feels like not knowing who you are without someone else's approval, and shape-shifting to fit whoever you're with.
• Chronic emptiness can look like flatness or "I'm just tired" to everyone else.
• Dissociation, feeling cut off from yourself or your surroundings, often under stress.
• Rejection sensitivity: replaying a conversation for days, reading a short text as proof someone is done with you.
• Self-harm or suicidal thoughts, kept hidden.

People with this presentation are often described as perfectionists, people-pleasers, or "the easy one" in the family. That's part of why the condition goes unrecognized.

Quiet BPD vs. "classic" BPD

The difference isn't severity. It's visibility.

In the presentation most people picture, distress spills outward: arguments, accusations, impulsive spending or drinking, visible crises in relationships. In quiet BPD, the same emotional storm happens internally. The person who might shout "you never cared about me" instead thinks "of course they don't care, I'm too much," and quietly stops replying to messages.

Both reflect the same underlying difficulty regulating emotions. Both cause real suffering. One is just far easier to overlook.

Why quiet BPD gets missed

Quiet BPD often arrives in a clinic labeled as something else, usually depression or anxiety. The internal pattern of shame, emptiness, and withdrawal overlaps heavily with both, and BPD frequently co-occurs with them: the NIMH notes that people with BPD may also experience depression, anxiety disorders, PTSD, eating disorders, and substance use disorders. If you're treated for depression alone and keep cycling back, the underlying pattern may not have been named. (For more on that overlap, see how anxiety and depression overlap.)

There's a second reason. People with quiet BPD are skilled at appearing okay, including in a therapist's office. They minimize. They worry about being a burden. A clinician who only sees the composed surface can miss what's underneath.

What causes quiet BPD?

No single cause explains BPD, quiet or otherwise. Genes and environment both contribute.

On the genetic side, a 2021 study of more than 1.8 million people in Swedish national registries estimated the heritability of diagnosed BPD at 46%. Risk was highest among identical twins and fell as relatives became more distant. The remaining variance came from environmental factors unique to each person.

On the environmental side, clinicians often hear about childhoods where feelings were dismissed, punished, or simply never acknowledged. Some people learned early that expressing anger or need made things worse, so they stopped. That's one plausible route from a sensitive temperament to an inward-facing pattern, though research hasn't yet separated what makes one person's BPD quiet and another's outward.

Self-harm and safety

Quiet doesn't mean low-risk. The NIMH notes that people with BPD are more likely to engage in self-harm, and the inward-facing pattern makes it easier to hide. Families sometimes learn about self-harm or suicidal thoughts only after a crisis.

If you or someone you love is having thoughts of suicide, call or text the 988 Suicide & Crisis Lifeline at 988. In an emergency, call 911.

Treatment for quiet BPD

BPD is treatable, and the evidence is strongest for specialized psychotherapy. A 2020 Cochrane review pooled 75 randomized trials with 4,507 participants. Across 22 trials comparing psychotherapy with usual care, therapy reduced BPD symptom severity. The two most-studied approaches were:

• Dialectical behavior therapy (DBT), which was developed specifically for BPD and teaches skills for intense emotions, distress tolerance, and relationships.
• Mentalization-based treatment (MBT), which builds the ability to understand your own and other people's mental states, especially under stress.

For quiet BPD, part of the work is simply making the inner experience visible: learning to notice and name anger, shame, and fear before they turn into silent withdrawal.

Medication plays a supporting role. According to the NIMH, the benefits of medication for BPD are unclear and it isn't a first-line treatment. Clinicians may use it alongside therapy for specific symptoms or co-occurring conditions such as depression.

Can quiet BPD get better?

Yes. There's no long-term research on quiet BPD specifically, but the data on BPD overall is more hopeful than most people expect. In a 10-year study of 290 adults with BPD first assessed during a psychiatric hospital stay, published in the American Journal of Psychiatry in 2010, 93% reached a symptom remission lasting at least two years. Full recovery, meaning remission plus good work and social functioning, was harder: about half got there. That gap is the case for treatment that goes beyond symptoms to rebuild relationships, work, and daily life.

How we treat BPD at Amae Health

Borderline Personality Disorder is one of the conditions our clinics specialize in. Our care teams bring psychiatrists, therapists, primary care physicians, peer mentors, and care coordinators under one roof, working from one treatment plan. For someone with quiet BPD, that matters: the more people who know your history, the harder it is for a composed surface to hide what's going on. Read more about how we approach care.

Frequently asked questions

Is quiet BPD real?

Yes, as a pattern. "Quiet BPD" isn't an official DSM-5 diagnosis, but it describes a recognized way borderline personality disorder can present, close to the "discouraged" subtype Theodore Millon described and the "internalizing" group seen in newer research.

Is there a test for quiet BPD?

There's no validated test for quiet BPD specifically. Online quizzes can prompt reflection, but a BPD diagnosis comes from a clinical evaluation by a mental health professional who looks at your history, patterns over time, and co-occurring conditions.

How is quiet BPD different from depression?

They overlap and often occur together. Depression centers on low mood and loss of interest. Quiet BPD adds intense fear of abandonment, an unstable sense of self, rapid shifts in mood, and relationship patterns driven by rejection sensitivity.

How can I help someone with quiet BPD?

Notice withdrawal instead of reading it as disinterest, and ask directly how they're doing. Avoid pressing for an explanation in the moment. Our guide on how to help someone with mental health issues covers more. If they mention self-harm or suicide, take it seriously and contact 988.

Key takeaways

• Quiet BPD is an informal name for borderline personality disorder expressed inward: hidden anger, shame, withdrawal, and self-blame.
• It's not a separate DSM-5 diagnosis, but research has identified a similar "internalizing" pattern.
• It's often mistaken for depression or anxiety, and self-harm can stay hidden.
• Specialized psychotherapy such as DBT and MBT has the strongest evidence, and long-term remission is common.

If you recognize yourself here, or you're worried about someone who seems fine but isn't, you can request an intake appointment. Our team will explain how an evaluation works and what to expect from your first visit.

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

• Early in treatment for depression
• Managing mild to moderate symptoms
• Looking to avoid in-clinic visits
• Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

• Has tried multiple antidepressants without adequate relief
• Cannot tolerate medication side effects
• Prefers a non-drug approach
• Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍